All Stories

  1. 3D-DXA Cortical and Trabecular Parameters: Agreement Between Hologic Densitometers in Clinical Practice
  2. Validation of 3D-DXA–Derived Proximal Femur Measurements Against QCT Across International Clinical Cohorts
  3. 3D-DXA based finite element modelling for femur strength prediction: evaluation against QCT.
  4. Is vitamin-D supplementation not useful in patients at risk of fractures and falls?
  5. 3D Analysis of Cortical and Trabecular Bone From Hip DXA:Precision and Trend Assessment Interval in PostmenopausalWomen
  6. SNPs in bone-related miRNAs are associated with the osteoporotic phenotype
  7. Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial
  8. 3D-DXA: Assessing the Femoral Shape, the Trabecular Macrostructure and the Cortex in 3D from DXA images
  9. Teriparatide and Risedronate After Hip Fracture
  10. Effets du tériparatide et du risédronate sur la DMO et la consolidation fracturaire chez des patients âgés avec fracture pertrochantérique récente : Résultats finaux d’un essai clinique randomisé de 78 semaines
  11. Exploring correlation between bone metabolism markers and densitometric traits in extended families from Spain
  12. Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
  13. Impact of 3-monthly vitamin D supplementation plus exercise on survival after surgery for osteoporotic hip fracture in adult patients over 50 years: A pragmatic randomized, partially blinded, controlled trial
  14. Genetics of Femoral Neck Geometry in Osteoporosis Risk
  15. Epicardial fat is a negative predictor of spine volumetric bone mineral density and trabecular bone score in acromegaly
  16. Exercise Improves Functional Capacity and Reduces Falls in Cirrhosis Patients
  17. Reduction of trabecular and cortical volumetric bone mineral density at the proximal femur in patients with acromegaly
  18. A PHASE 2 RANDOMIZED STUDY INVESTIGATING THE EFFICACY AND SAFETY OF MYOSTATIN ANTIBODY LY2495655 VERSUS PLACEBO IN PATIENTS UNDERGOING ELECTIVE TOTAL HIP ARTHROPLASTY
  19. Pharmacological Treatment of Osteoporosis
  20. Caso clínico a debate: vacaciones terapéuticas, ¿sí o no?
  21. Caso clínico a debate: vacaciones terapéuticas: ¿sí o no?
  22. Genetic Analysis of High Bone Mass Cases from the BARCOS Cohort of Spanish Postmenopausal Women
  23. Heritability of Bone Mineral Density in a Multivariate Family-Based Study
  24. Documento de consenso: Recomendaciones para el manejo de la enfermedad ósea metabólica en pacientes con virus de la inmunodeficiencia humana
  25. Linkage and association analyses using families identified a locus affecting an osteoporosis-related trait
  26. Low calcium intake and inadequate vitamin D status in postmenopausal osteoporotic women
  27. Psychopathology and psychosocial adjustment in patients with HIV-associated lipodystrophy
  28. Fat Tissue Measurements by Dual-Energy X-Ray Absorptiometry: Cross-Calibration of 3 Different Fan-Beam Instruments
  29. Pharmacological Treatment of Osteoporosis
  30. Age-Related Changes in Vertebral Morphometry by Statistical Shape Analysis
  31. Manejo del paciente con alto riesgo de fractura en la práctica clínica. Resultados de una encuesta a 174 reumatólogos españoles (proyecto OSTEOPAR)
  32. Defining High Risk of Osteoporotic Fracture
  33. Comparative effects of teriparatide and strontium ranelate in the periosteum of iliac crest biopsies in postmenopausal women with osteoporosis
  34. Prevalence of vertebral fracture in postmenopausal women with lumbar osteopenia using MorphoXpressSR (OSTEOXPRESS Study)
  35. Analgesic use and pain in the hospital settings
  36. Prevalence of pain in adults admitted to Catalonian hospitals: A cross-sectional study
  37. A Survey of Perceptions with Pain Management in Spanish Inpatients
  38. Protocolo de actuaci?n diagn?stica y terap?utica ante una fractura vertebral